Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Chia Tai Tianqing Pharmaceutical
Chia Tai Tianqing Pharmaceutical
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Fosaprepitant dimeglumine
Fosaprepitant dimeglumine
2021-03-03
—
Fulvestrant
Fulvestrant
2020-02-07
2034
Breast neoplasms
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Fulvestrant
healthy volunteers/patients
,
pharmacokinetics
,
lymphoma
,
non-hodgkin lymphoma
,
acrocephalosyndactylia
,
endometrioid carcinoma
,
peritoneal neoplasms
,
hereditary breast and ovarian cancer syndrome
,
malignant mesothelioma
,
mesothelioma
,
pharmacological phenomena
,
adenocarcinoma
,
carcinosarcoma
,
digestive system neoplasms
,
urinary bladder neoplasms
,
neuroendocrine tumors
,
islet cell adenoma
,
urogenital neoplasms
,
female genital neoplasms
,
esophageal neoplasms
,
colonic neoplasms
,
spinocerebellar degenerations
,
fibrosis
,
inguinal hernia
,
hernia
,
gangrene
,
ovarian neoplasms
,
endometrial neoplasms
,
non-small-cell lung carcinoma
,
prostatic neoplasms
,
ovarian epithelial carcinoma
,
colorectal neoplasms
,
squamous cell carcinoma of head and neck
,
uterine cervical neoplasms
,
lung neoplasms
,
postmenopause
,
castration-resistant prostatic neoplasms
,
fallopian tube neoplasms
,
small cell lung carcinoma
,
breast diseases
,
stomach neoplasms
,
ductal carcinoma
,
liposarcoma
,
pancreatic neoplasms
,
carcinoma in situ
,
head and neck neoplasms
,
neoplasms by site
,
urologic neoplasms
,
uterine neoplasms
,
brain neoplasms
,
circulating neoplastic cells
,
intraductal carcinoma noninfiltrating
,
syndrome
,
sarcoma
,
melanoma
,
transitional cell carcinoma
,
squamous cell carcinoma
,
radiosurgery
,
biliary tract neoplasms
,
adenocarcinoma of lung
,
serous cystadenocarcinoma
,
leiomyosarcoma
,
adenosarcoma
,
sex cord-gonadal stromal tumors
,
endometrial stromal sarcoma
,
bone neoplasms
,
hypertension
,
pulmonary arterial hypertension
,
familial primary pulmonary hypertension
,
systemic lupus erythematosus
,
precocious puberty
,
polyostotic fibrous dysplasia
,
inborn genetic diseases
,
neutropenia
,
insulin resistance
,
hyperglycemia
,
hyperinsulinism
,
molecular targeted therapy
,
large b-cell lymphoma diffuse
,
salivary gland neoplasms
,
therapeutics
,
myxoid liposarcoma
,
esophageal squamous cell carcinoma
,
squamous cell neoplasms
,
skin neoplasms
,
diarrhea
,
exanthema
,
type 2 diabetes mellitus
,
carcinoma
,
recurrence
,
male breast neoplasms
,
hereditary sensory and autonomic neuropathies
,
invasive hydatidiform mole
,
disease progression
,
lobular carcinoma
,
ductal carcinoma breast
,
neoadjuvant therapy
,
progression-free survival
,
cholangiocarcinoma
,
unilateral breast neoplasms
,
breast neoplasms
,
neoplasms
,
triple negative breast neoplasms
,
neoplasm metastasis
,
multiple endocrine neoplasia type 1
,
eye abnormalities
Sintilimab
osteosarcoma
,
drug-related side effects and adverse reactions
,
adenocarcinoma of lung
,
meningeal carcinomatosis
,
gastrointestinal stromal tumors
,
pancreatic neoplasms
,
cholangiocarcinoma
,
biliary tract neoplasms
,
t-cell lymphoma peripheral
,
t-cell lymphoma
,
uterine cervical neoplasms
,
drug therapy
,
colonic neoplasms
,
healthy volunteers/patients
,
large b-cell lymphoma diffuse
,
sarcoma
,
chemoradiotherapy
,
molecular targeted therapy
,
b-cell lymphoma
,
neuroendocrine carcinoma
,
glioblastoma
,
chronic hepatitis b
,
thoracic neoplasms
,
ovarian neoplasms
,
neuroendocrine tumors
,
brain neoplasms
,
neuroblastoma
,
disease
,
multiple primary neoplasms
,
t-cell lymphoma cutaneous
,
microsatellite instability
,
malignant mesothelioma
,
mesothelioma
,
radiosurgery
,
residual neoplasm
,
gastrointestinal neoplasms
,
digestive system neoplasms
,
ascites
,
clear cell adenocarcinoma
,
adenomyoepithelioma
,
mutation rate
,
microsatellite repeats
,
immunoblastic lymphadenopathy
,
adoptive immunotherapy
,
respiratory tract diseases
,
lung diseases
,
precancerous conditions
,
aortic dissection
,
perioperative period
,
salivary gland neoplasms
,
unknown primary neoplasms
,
malignant fibrous histiocytoma
,
disorders of sex development
,
hemangiosarcoma
,
gastrectomy
,
astrocytoma
,
oligodendroglioma
,
skin neoplasms
,
cutaneous malignant melanoma
,
appendiceal neoplasms
,
gallbladder neoplasms
,
lymphatic metastasis
,
head and neck neoplasms
,
airway obstruction
,
intensity-modulated radiotherapy
,
maintenance chemotherapy
,
follicular lymphoma
,
mantle-cell lymphoma
,
central nervous system neoplasms
,
vaginal neoplasms
,
vulvar neoplasms
,
spinocerebellar degenerations
,
hiv
,
acquired immunodeficiency syndrome
,
opportunistic infections
,
kidney neoplasms
,
sebaceous adenocarcinoma
,
pancreatic ductal carcinoma
,
ablation techniques
,
hepatocellular carcinoma
,
carcinoma
,
neoplasms
,
colorectal neoplasms
,
esophageal squamous cell carcinoma
,
squamous cell carcinoma
,
immunotherapy
,
neoplasm metastasis
,
rectal neoplasms
,
esophageal neoplasms
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
squamous cell carcinoma of head and neck
,
recurrence
,
small cell lung carcinoma
,
neoadjuvant therapy
,
radiotherapy
,
renal cell carcinoma
,
extranodal nk-t-cell lymphoma
,
endometrial neoplasms
,
thrombosis
,
melanoma
,
squamous cell neoplasms
,
mouth neoplasms
,
anus neoplasms
,
gastrointestinal diseases
,
esophageal diseases
,
hepatoblastoma
,
radiation pneumonitis
,
adjuvant chemotherapy
,
adjuvant radiotherapy
,
fertility
,
epstein-barr virus infections
,
liver neoplasms
,
non-small-cell lung carcinoma
,
stomach neoplasms
,
lung neoplasms
,
adenocarcinoma
,
lymphoma
,
breast neoplasms
,
hodgkin disease
,
triple negative breast neoplasms
,
thyroid neoplasms
,
thyroid diseases
,
liver diseases
,
gastrointestinal microbiome
,
catheter ablation
,
female genital neoplasms
,
abdominal neoplasms
,
meningioma
,
venous thrombosis
,
hemophagocytic lymphohistiocytosis
,
analgesia
,
agnosia
,
delirium
,
acute kidney injury
,
tumor microenvironment
,
hepatitis b
,
hepatitis
,
chronic hepatitis
,
endometrioid carcinoma
,
leukemia
,
progression-free survival
Cadonilimab
biliary tract neoplasms
Lanifibranor
healthy volunteers/patients
,
pharmacokinetics
,
type 2 diabetes mellitus
,
fatty liver
,
diabetes mellitus
,
systemic scleroderma
,
diffuse scleroderma
,
sclerosis
,
non-alcoholic fatty liver disease
,
liver diseases
,
fibrosis
Faropenem
bacterial pneumonia
,
pneumonia
,
community-acquired pneumonia
Catequentinib
neoplasms
,
lung neoplasms
Capeox
adenocarcinoma
Endocrine
neoplasm metastasis
,
prostatic neoplasms
,
carcinoma
,
carcinoid tumor
,
neuroendocrine carcinoma
,
castration-resistant prostatic neoplasms
,
breast diseases
,
hereditary sensory and autonomic neuropathies
,
endocrine gland neoplasms
,
islet cell carcinoma
,
malignant carcinoid syndrome
,
serotonin syndrome
,
recurrence
,
small cell lung carcinoma
,
lobular carcinoma
,
ductal carcinoma breast
,
breast neoplasms
,
neoplasms
,
triple negative breast neoplasms
,
neuroendocrine tumors
,
male breast neoplasms
,
pancreatic neoplasms
,
heart failure
,
thalassemia
,
hypoglycemia
,
islet cell adenoma
,
multiple endocrine neoplasia type 1
,
iron overload
Tqb3454
neoplasms
,
myelodysplastic syndromes
,
myeloid leukemia acute
,
biliary tract neoplasms
,
carcinoma
Tqb3473
hematologic neoplasms
,
neoplasms
,
thrombocytopenic purpura idiopathic
,
thrombocytopenia
TQB3617
neoplasms
,
esophageal squamous cell carcinoma
,
primary myelofibrosis
TQB3720
castration-resistant prostatic neoplasms
TQB3728
neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
Tqz2451
type 2 diabetes mellitus
Tqc2731
asthma
,
sinusitis
,
nasal polyps
,
polyps
,
paranasal sinus diseases
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use